Current Opinion in Hematology

Papers
(The H4-Index of Current Opinion in Hematology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis38
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia26
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis24
Deficits in our understanding of natural killer cell development in mouse and human23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective21
Age-dependent regulation of hematopoiesis by megakaryocytes21
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis20
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function20
Disparities in acute myeloid leukemia treatments and outcomes18
Mesenchymal stromal cells: an update18
Developmental regulation of primitive erythropoiesis17
Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives16
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation16
The impact of obesity-induced inflammation on clonal hematopoiesis15
Platelet lifespan and mechanisms for clearance15
0.0971360206604